Originally Posted by Bwana:
Once again, don't come in this thread with some kind of political agenda, or you will be shown the door. If you want to go that route, there is a thread about this in DC.
Originally Posted by Dartgod:
People, there is a lot of good information in this thread, let's try to keep the petty bickering to a minimum.
We all have varying opinions about the impact of this, the numbers, etc. We will all never agree with each other. But we can all keep it civil.
Thanks!
Click here for the original OP:
Spoiler!
Apparently the CoronaVirus can survive on a inanimate objects, such as door knobs, for 9 days.
California coronavirus case could be first spread within U.S. community, CDC says
By SOUMYA KARLAMANGLA, JACLYN COSGROVE
FEB. 26, 2020 8:04 PM
The Centers for Disease Control and Prevention is investigating what could be the first case of novel coronavirus in the United States involving a patient in California who neither recently traveled out of the country nor was in contact with someone who did.
“At this time, the patient’s exposure is unknown. It’s possible this could be an instance of community spread of COVID-19, which would be the first time this has happened in the United States,” the CDC said in a statement. “Community spread means spread of an illness for which the source of infection is unknown. It’s also possible, however, that the patient may have been exposed to a returned traveler who was infected.”
The individual is a resident of Solano County and is receiving medical care in Sacramento County, according to the state Department of Public Health.
The CDC said the “case was detected through the U.S. public health system — picked up by astute clinicians.”
Officials at UC Davis Medical Center expanded on what the federal agency might have meant by that in an email sent Wednesday, as reported by the Davis Enterprise newspaper.
The patient arrived at UC Davis Medical Center from another hospital Feb. 19 and “had already been intubated, was on a ventilator, and given droplet protection orders because of an undiagnosed and suspected viral condition,” according to an email sent by UC Davis officials that was obtained by the Davis Enterprise.
The staff at UC Davis requested COVID-19 testing by the CDC, but because the patient didn’t fit the CDC’s existing criteria for the virus, a test wasn’t immediately administered, according to the email. The CDC then ordered the test Sunday, and results were announced Wednesday. Hospital administrators reportedly said in the email that despite these issues, there has been minimal exposure at the hospital because of safety protocols they have in place.
A UC Davis Health spokesperson declined Wednesday evening to share the email with The Times.
Since Feb. 2, more than 8,400 returning travelers from China have entered California, according to the state health department. They have been advised to self-quarantine for 14 days and limit interactions with others as much as possible, officials said.
“This is a new virus, and while we are still learning about it, there is a lot we already know,” Dr. Sonia Angell, director of the California Department of Public Health, said in a statement. “We have been anticipating the potential for such a case in the U.S., and given our close familial, social and business relationships with China, it is not unexpected that the first case in the U.S. would be in California.”
It is not clear how the person became infected, but public health workers could not identify any contacts with people who had traveled to China or other areas where the virus is widespread. That raises concern that the virus is spreading in the United States, creating a challenge for public health officials, experts say.
“It’s the first signal that we could be having silent transmission in the community,” said Lawrence Gostin, director of the World Health Organization Collaborating Center on National and Global Health Law. “It probably means there are many more cases out there, and it probably means this individual has infected others, and now it’s a race to try to find out who that person has infected.”
On Tuesday, the CDC offered its most serious warning to date that the United States should expect and prepare for the coronavirus to become a more widespread health issue.
“Ultimately, we expect we will see coronavirus spread in this country,” said Nancy Messonnier, director of the CDC’s National Center for Immunization and Respiratory Diseases. “It’s not so much a question of if, but a question of when.”
According to the CDC’s latest count Wednesday morning, 59 U.S. residents have tested positive for the new strain of coronavirus — 42 of whom are repatriated citizens from a Diamond Princess cruise. That number has grown by two since Messonnier’s last count Tuesday, although the CDC was not immediately available to offer details on the additional cases.
More than 82,000 cases of coronavirus have been reported globally, and more than 2,700 people have died, with the majority in mainland China, the epicenter of the outbreak.
But public health leaders have repeatedly reminded residents that the health risk from the novel coronavirus to the general public remains low.
“While COVID-19 has a high transmission rate, it has a low mortality rate,” the state Department of Public Health said in a statement Wednesday. “From the international data we have, of those who have tested positive for COVID-19, approximately 80% do not exhibit symptoms that would require hospitalization. There have been no confirmed deaths related to COVID-19 in the United States to date.”
CDC officials have also warned that although the virus is likely to spread in U.S. communities, the flu still poses a greater risk.
Gostin said the news of potential silent transmission does not eliminate the possibility of containing the virus in the U.S. and preventing an outbreak.
“There are few enough cases that we should at least try,” he said. “Most of us are not optimistic that that will be successful, but we’re still in the position to try.”
(The FB profile changes happened 5 weeks and 3 weeks ago, respectively.)
The COVID variant in India seems to be hitting the age 20-45 population really hard. The majority of my team is in India and it's been brutal. They don't have access to the vaccine yet. A guy who worked on my team last year just died last week. Age 25 and healthy. Had just gotten married and was planning to move to the U.S.
I had previously thought I really didn't care about getting the vaccine, but I went ahead and got Pfizer just because it's available at my Hy-Vee and they made it so easy. Seemed like why not? Trying to encourage others to but many friends and family just think it's unnecessary. Weird to see India where people are desperate for it, but can't get it. [Reply]
Originally Posted by wazu:
The COVID variant in India seems to be hitting the age 20-45 population really hard. The majority of my team is in India and it's been brutal. They don't have access to the vaccine yet. A guy who worked on my team last year just died last week. Age 25 and healthy. Had just gotten married and was planning to move to the U.S.
I had previously thought I really didn't care about getting the vaccine, but I went ahead and got Pfizer just because it's available at my Hy-Vee and they made it so easy. Seemed like why not? Trying to encourage others to but many friends and family just think it's unnecessary. Weird to see India where people are desperate for it, but can't get it.
The Pfizer vaccine has shown to be very effective against all variants so far. I don't expect that to change. Hopefully they can start getting it into arms in India soon. [Reply]
Originally Posted by TLO:
The Pfizer vaccine has shown to be very effective against all variants so far. I don't expect that to change. Hopefully they can start getting it into arms in India soon.
Yep:
May 25, 2021 -- A study found that two doses of the Pfizer/BioNTech or the Astra/Zeneca vaccine protect against the COVID-19 variant first detected in India -- as well as the variant first found in the United Kingdom.
The study emphasized the need for two doses, saying one dose of the vaccines provided much less protection.
The Public Health England study looked at health data from 1,054 people of different ages and ethnicities in April and May.
The study said the Pfizer vaccine was 88% effective against the B.1.617.2 variant, first found in India, 2 weeks after the second dose. The Pfizer vaccine was 93% effective against the variant found in the U.K., known as B.1.1.7, two weeks after the second dose.
Two doses of the AstraZeneca vaccine were 60% effective against the B.1.617.2 variant and 66% effective against B.1.1.7, the study said.
But one dose didn’t work nearly as well, the study said. Three weeks after the first dose, both vaccines provided only 33% effectiveness against B.1.617.2 and 50% effectiveness against B.1.1.7.
The study concluded, “After 2 doses of either vaccine there were only modest differences in vaccine effectiveness with the B.1.617.2 variant. Absolute differences in vaccine effectiveness were more marked with dose 1. This would support maximizing vaccine uptake with 2 doses among vulnerable groups.”
Jenny Harries, the chief executive of the U.K. Health Security Agency, hailed the study as the "first real-world evidence of vaccine effectiveness" against the variant, according to the BBC.
“This evidence is groundbreaking & shows how important the 2nd dose is to secure the strongest protection against COVID-19,” U.K. Health Secretary Matt Hancock said in a tweet. “Thank you to the scientists & clinicians who've been working to produce this research. It’s vital to get both jabs.”
The study authors said the different effectiveness of the vaccines after two doses might be explained by the earlier rollout of the Pfizer vaccine.
The BBC said the Moderna vaccine has also been used in the U.K. since April, but the numbers were too small to be included in the study.
Health experts say the B.1.617.2 variant is one of the main reasons India is having a difficult time bringing the pandemic under control.
India now has the second most confirmed coronavirus cases in the world (26.7 million, behind the United States’ 33.1 million) and the third most deaths (303,000; behind 590,000 in the U.S. and 449,000 in Brazil).
B.1.1.7 is now the dominant strain in the U.K. [Reply]
Originally Posted by TLO:
To be honest, 90%+ effectiveness on the first try for a vaccine that is completed in less than a year might be one of mankind's greatest achievements. (Unless something catastrophic happens and it falls apart)
Originally Posted by wazu:
The COVID variant in India seems to be hitting the age 20-45 population really hard. The majority of my team is in India and it's been brutal. They don't have access to the vaccine yet. A guy who worked on my team last year just died last week. Age 25 and healthy. Had just gotten married and was planning to move to the U.S.
I had previously thought I really didn't care about getting the vaccine, but I went ahead and got Pfizer just because it's available at my Hy-Vee and they made it so easy. Seemed like why not? Trying to encourage others to but many friends and family just think it's unnecessary. Weird to see India where people are desperate for it, but can't get it.
I don't expect it to hit all at once where it fills up ICU beds to capacity. But the nastier variants are going to circulate in the US.
People who had the original virus but don't get vaccinated may or may not get super sick but they will likely be able to spread it and those who have neither been vaccinated nor had had the original virus will be at risk of getting seriously ill or dying. And yes it is hitting a younger age group.
Georgia is at something like 30% vaccinated and I'm sure there are pockets of the country that are worse. [Reply]
Originally Posted by Doctor Fauci:
Per CDC guidelines, you need to wait a full 2 weeks after receiving your second shot before you are considered fully protected.
Please continue masking until then.
Thank you.
Good to have you posting here, Doctor Fauci. Welcome. [Reply]
I have been seeing an increased number of patients coming in for axillary and supraclavicular lymphadenopathy post vaccinations , it is not something I normally see during flu shot season, if the body is reacting this much to the imposter you can see how the a dose of the real could kick your immune system in the teeth, or maybe these new vaccine are just more effective at getting an immune response making them more efficient and protecting you . [Reply]
Originally Posted by Doctor Fauci:
Case numbers yesterday were minuscule. So were deaths.
Yes, but only 29 states reported cases, and only 16 reported deaths. Weekend lag, plus Memorial Day. It'll probably be Wednesday until things are clearer. [Reply]
Originally Posted by TLO:
The Pfizer vaccine has shown to be very effective against all variants so far. I don't expect that to change. Hopefully they can start getting it into arms in India soon.
Inject into the cock, so I don't have to read about "ehr mah gawd get shots in err arms" anymore [Reply]